This message was posted by a user wishing to remain anonymous
Hi Everyone,
looking to shed some light...
I have company A (located in Europe) who manufactures API and ships the API to company B (also located in Europe) who is the holder and owner of the DMF. Company B ships the API to company C (located in Europe), who uses the API for further processing, and ships X amount to Company D (located in US).
Company A is the manufacturer
Company B is the supplier and owner of the DMF. The Certificate of Analysis is provided by company B.
Company C supplies x amount to company D
Who should drug list the API? Company A (manufacturer) or Company B (holder/owner of the DMF)? Company B think they don't have to register because they are not the manufacturer even though they are the holder/owner of the DMF.
Per the FD&C Act, looks like company A should list it...
"Section 510 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) requires firms that manufacture, prepare, propagate, compound, or process drugs in the U.S. or that are offered for import into the U.S. to
register with the FDA. These domestic and foreign firms must at the time of registration,
list all drugs manufactured, prepared, propagated, compounded, or processed for commercial distribution in the U.S."
Any thoughts? Comments?
Thank you for you help!